The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue
Long COVID
About this trial
This is an interventional treatment trial for Long COVID focused on measuring fatigue, Chinese herbal medicine
Eligibility Criteria
Inclusion Criteria: 18-65 years adults Fulfill the long COVID diagnostic criteria by Centers for Disease Control and Prevention (CDC) Chalder fatigue scale (0-11) not less than 4 Exclusion Criteria: Have any medical history that may cause fatigue before COVID-19 infection, which include but not limited to cardiovascular diseases, chronic lung diseases, dyspnea, cognitive diseases, psychological diseases, chronic liver or renal diseases, cancer, etc. Must chronically taking medicines that may affect the study results. Severe obesity (BMI not less than 45) Alcoholism or drug abuse Allergy to Chinese medicine Pregnancy, or plan to be pregnant, or lactating women
Sites / Locations
- Hong Kong Baptist University Chinese Medicine ClinicRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Treatment group
Control group
Subjects need to take the Chinese herbal medicine (Shenlingcao oral liquid) 200 ml twice per day for 4 weeks. Shenlingcao oral solution is comprised of American Ginseng (Panacis Quinquefolii Radix), Lucid Ganoderma (Ganoderma), Rose (Rosae Rugosae Flos) and fermented Cordyceps powder.
Subjects need to take the placebo of Shenlingcao oral liquid 200 ml twice per day for 4 weeks.